<DOC>
	<DOCNO>NCT02918357</DOCNO>
	<brief_summary>The investigator image patient prostate cancer use new PET imaging agent ( Ga-68-PSMA-11 ) order evaluate 's ability detection prostate cancer patient biochemical recurrence prostatectomy radiation therapy .</brief_summary>
	<brief_title>Gallium-68 PSMA-11 PET Patients With Biochemical Recurrence</brief_title>
	<detailed_description>Imaging stag prostate cancer critical surgical treatment planning . Patients suspect metastatic prostate cancer image use Gallium-68 label PSMA-11 order demonstrate utility . The investigator plan utilize data obtain approval Ga-68-PSMA-11 compound , agent become available clinical imaging prostate cancer patient . In biochemical recurrence population , primary objective determine sensitivity positive predictive value ( PPV ) per-patient per-region-basis 68Ga-PSMA-11 PET detection tumor location confirm histopathology/biopsy .</detailed_description>
	<mesh_term>Recurrence</mesh_term>
	<criteria>Histopathological proven prostate adenocarcinoma . Rising PSA definitive therapy prostatectomy radiation therapy ( external beam brachytherapy ) . Post radical prostatectomy ( RP ) AUA recommendation PSA great 0.2 ng/mL measure 6 week RP , Confirmatory persistent PSA great 0.2 ng/mL Postradiation therapy ASTROPhoenix consensus definition Nadir + great equal 2 ng/mL rise PSA Karnofsky performance status great 50 ( ECOG/WHO equivalent ) . Age &gt; 18 . Ability understand write informed consent document , willingness sign . Investigational therapy prostate cancer . Unable lie flat , still tolerate PET scan . Prior history malignancy within last 2 year , skin basal cell cutaneous superficial squamous cell carcinoma metastasize superficial bladder cancer . Contraindication furosemide administration include prior allergy adverse reaction furosemide sulfa drug . ( Note : This exclusion criterion remove Furosemide omit part PET image protocol secondgeneration scatter correction available use PET device ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>